Molecular Biology of Polycythemia and Thrombocytosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Utah
About this trial
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Eligibility criteria
Qualifiers
Subjects with an elevated hemoglobin concentration (>18 in males and >16 in females)
Subjects with an elevated platelet count (>450,000)
Disqualifiers
Subjects who have a known acquired cause of polycythemia and thrombocytosis
Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Utah
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov